Sign inGet started

Ho Peter Tai-Ching

Insider CIK 1619052 · ARAV Director · EPZM Chief Development Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ARAV Aravive, Inc. A Award deriv2022-10-242022-10-2627,176— $027,176SEC↗
ARAV Aravive, Inc. A Award deriv2022-10-242022-10-2627,177— $027,177SEC↗
ARAV Aravive, Inc. A Award deriv2022-10-242022-10-2727,176— $027,176SEC↗
ARAV Aravive, Inc. A Award deriv2022-10-242022-10-2727,177— $027,177SEC↗
ARAV Aravive, Inc. A Award2022-10-242022-10-2654,353$0.92 $50.0K55,353SEC↗
ARAV Aravive, Inc. A Award2022-10-242022-10-2754,353$0.92 $50.0K55,353SEC↗
ARAV Aravive, Inc. A Award deriv2022-09-232022-09-2697,063— $097,063SEC↗
ARAV Aravive, Inc. A Award deriv2021-09-102021-09-1322,812— $022,812SEC↗
ARAV Aravive, Inc. A Award deriv2021-07-012021-07-0215,435— $015,435SEC↗
ARAV Aravive, Inc. A Award deriv2021-07-012021-07-025,245— $05,245SEC↗
EPZM Epizyme, Inc. M Exercise deriv2017-10-242017-10-2515,000— $05,500SEC↗
EPZM Epizyme, Inc. M Exercise2017-10-242017-10-2515,000$8.98 $134.7K23,123SEC↗
EPZM Epizyme, Inc. S Sale2017-10-242017-10-2515,000$16.44 $246.6K8,123SEC↗
EPZM Epizyme, Inc. M Exercise deriv2017-09-252017-09-2615,000— $015,725SEC↗
EPZM Epizyme, Inc. S Sale2017-09-252017-09-2615,000$16.81 $252.1K8,123SEC↗
EPZM Epizyme, Inc. M Exercise2017-09-252017-09-2615,000$8.98 $134.7K23,123SEC↗
EPZM Epizyme, Inc. M Exercise deriv2017-08-242017-08-2815,000— $025,950SEC↗
EPZM Epizyme, Inc. S Sale2017-08-242017-08-2815,000$15.68 $235.2K7,228SEC↗
EPZM Epizyme, Inc. M Exercise2017-08-242017-08-2815,000$8.98 $134.7K22,228SEC↗
EPZM Epizyme, Inc. M Exercise deriv2017-07-242017-07-2615,000— $036,175SEC↗
EPZM Epizyme, Inc. S Sale2017-07-242017-07-2615,000$13.44 $201.6K7,228SEC↗
EPZM Epizyme, Inc. M Exercise2017-07-242017-07-2615,000$8.98 $134.7K22,228SEC↗
EPZM Epizyme, Inc. M Exercise deriv2017-06-262017-06-2715,000— $046,400SEC↗
EPZM Epizyme, Inc. S Sale2017-06-262017-06-2715,000$14.87 $223.1K7,228SEC↗
EPZM Epizyme, Inc. M Exercise2017-06-262017-06-2715,000$8.98 $134.7K22,228SEC↗
EPZM Epizyme, Inc. M Exercise deriv2017-05-252017-05-2615,000— $056,625SEC↗
EPZM Epizyme, Inc. M Exercise2017-05-252017-05-2615,000$8.98 $134.7K22,228SEC↗
EPZM Epizyme, Inc. S Sale2017-05-252017-05-2615,000$16.11 $241.7K7,228SEC↗
EPZM Epizyme, Inc. A Award2017-02-282017-03-021,708$6.21 $10.6K7,228SEC↗
EPZM Epizyme, Inc. A Award deriv2017-02-082017-02-09122,074— $0122,074SEC↗
EPZM Epizyme, Inc. S Sale2016-12-082016-12-12200$10.89 $2.2K5,520SEC↗
EPZM Epizyme, Inc. A Award2016-08-312016-09-011,362$6.21 $8.5K5,720SEC↗
EPZM Epizyme, Inc. P Buy2016-02-292016-03-02636$7.47 $4.8K5,358SEC↗
EPZM Epizyme, Inc. A Award deriv2016-02-082016-02-10229,200— $0229,200SEC↗
EPZM Epizyme, Inc. P Buy2015-12-092015-12-101,000$14.69 $14.7K4,722SEC↗
EPZM Epizyme, Inc. P Buy2015-08-312015-09-02522$17.00 $8.9K3,522SEC↗
EPZM Epizyme, Inc. P Buy2015-08-202016-03-312,000$16.51 $33.0K2,200SEC↗
EPZM Epizyme, Inc. P Buy2015-08-202015-08-242,000$16.51 $33.0K3,000SEC↗
EPZM Epizyme, Inc. P Buy2015-05-052015-05-06400$16.36 $6.5K1,000SEC↗
EPZM Epizyme, Inc. P Buy2015-05-052015-05-06400$16.36 $6.5K1,000SEC↗
EPZM Epizyme, Inc. A Award deriv2015-02-132015-02-1735,778— $035,778SEC↗
EPZM Epizyme, Inc. P Buy2014-12-162014-12-18200$17.63 $3.5K600SEC↗
EPZM Epizyme, Inc. P Buy2014-12-162014-12-18200$17.63 $3.5K600SEC↗
EPZM Epizyme, Inc. P Buy2014-12-022014-12-04400$21.16 $8.5K400SEC↗
EPZM Epizyme, Inc. P Buy2014-12-022014-12-04200$21.19 $4.2K200SEC↗
EPZM Epizyme, Inc. P Buy2014-12-022014-12-04400$21.16 $8.5K400SEC↗
EPZM Epizyme, Inc. A Award deriv2014-09-112014-09-15150,000— $0150,000SEC↗